Cardiovascular Diabetology | |
Vitamin D supplementation as an adjuvant therapy for patients with T2DM: an 18-month prospective interventional study | |
Original Investigation | |
Emad El-Kholie1  Khalid M Alkharfy2  Majed S Alokail3  Nasser M Al-Daghri3  George P Chrousos4  Shaun Sabico5  Sudhesh Kumar6  Abdulaziz Al-Othman7  Osama Moharram8  Yousef Al-Saleh9  | |
[1] Biomarkers Research Program, Biochemistry Department, College of Science, King Saud University, PO Box, 2455, 11451, Riyadh, Kingdom of Saudi Arabia;Biomarkers Research Program, Biochemistry Department, College of Science, King Saud University, PO Box, 2455, 11451, Riyadh, Kingdom of Saudi Arabia;Center of Excellence in Biotechnology Research Center, King Saud University, 11451, Riyadh, Kingdom of Saudi Arabia;Clinical Pharmacy Department, College of Pharmacy, King Saud University, 11451, Riyadh, Kingdom of Saudi Arabia;Biomarkers Research Program, Biochemistry Department, College of Science, King Saud University, PO Box, 2455, 11451, Riyadh, Kingdom of Saudi Arabia;Center of Excellence in Biotechnology Research Center, King Saud University, 11451, Riyadh, Kingdom of Saudi Arabia;Prince Mutaib Chair for Biomarkers of Osteoporosis, King Saud University, 11451, Riyadh, Kingdom of Saudi Arabia;Biomarkers Research Program, Biochemistry Department, College of Science, King Saud University, PO Box, 2455, 11451, Riyadh, Kingdom of Saudi Arabia;First Department of Pediatrics, Athens University Medical School, 11527, Athens, Greece;Biomarkers Research Program, Biochemistry Department, College of Science, King Saud University, PO Box, 2455, 11451, Riyadh, Kingdom of Saudi Arabia;Prince Mutaib Chair for Biomarkers of Osteoporosis, King Saud University, 11451, Riyadh, Kingdom of Saudi Arabia;Clinical Sciences Research Institute, Diabetes and Metabolism Unit, CV47AL, Coventry, UK;College of Applied Medical Sciences, King Saud University, 11451, Riyadh, Kingdom of Saudi Arabia;King Abdulaziz University Hospital, King Saud University, 11451, Riyadh, Kingdom of Saudi Arabia;Prince Mutaib Chair for Biomarkers of Osteoporosis, King Saud University, 11451, Riyadh, Kingdom of Saudi Arabia;College of Medicine, King Saud University for Health Sciences, 11426, Riyadh, Kingdom of Saudi Arabia; | |
关键词: Vitamin D; Diabetes mellitus; Saudi; Supplementation; | |
DOI : 10.1186/1475-2840-11-85 | |
received in 2012-06-02, accepted in 2012-07-18, 发布年份 2012 | |
来源: Springer | |
【 摘 要 】
BackgroundVitamin D deficiency has been associated with impaired human insulin action, suggesting a role in the pathogenesis of diabetes mellitus type 2 (T2DM). In this prospective interventional study we investigated the effects of vitamin D3 supplementation on the metabolic profiles of Saudi T2DM subjects pre- and post-vitamin D supplementation over an 18-month period.MethodsT2DM Saudi subjects (men, N = 34: Age: 56.6 ± 8.7 yr, BMI, 29.1 ± 3.3 kg/m2; women, N = 58: Age: 51.2 ± 10.6 yr, BMI 34.3 ± 4.9 kg/m2;) were recruited and given 2000 IU vitamin D3 daily for 18 months. Anthropometrics and fasting blood were collected (0, 6, 12, 18 months) to monitor serum 25-hydroxyvitamin D using specific ELISA, and to determine metabolic profiles by standard methods.ResultsIn all subjects there was a significant increase in mean 25-hydroxyvitamin D levels from baseline (32.2 ± 1.5 nmol/L) to 18 months (54.7 ± 1.5 nmol/L; p < 0.001), as well as serum calcium (baseline = 2.3 ± 0.23 mmol/L vs. 18 months = 2.6 ± 0.1 mmol/L; p = 0.003). A significant decrease in LDL- (baseline = 4.4 ± 0.8 mmol/L vs. 18 months = 3.6 ± 0.8 mmol/L, p < 0.001] and total cholesterol (baseline = 5.4 ± 0.2 mmol/L vs. 18 months = 4.9 ± 0.3 mmol/L, p < 0.001) were noted, as well as a significant improvement in HOMA-β function ( p = 0.002). Majority of the improvements elicited were more prominent in women than men.ConclusionIn the Saudi T2DM population receiving oral Vitamin D3 supplementation (2000 IU/day), circulating 25-hydroxyvitamin D levels remained below normal 18 months after the onset of treatment. Yet, this “suboptimal” supplementation significantly improved lipid profile with a favorable change in HDL/LDL ratio, and HOMA-β function, which were more pronounced in T2DM females.
【 授权许可】
CC BY
© Al-Daghri et al.; licensee BioMed Central Ltd. 2012
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202311109191163ZK.pdf | 339KB | download |
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]
- [35]
- [36]